(1,1′-dimethyl-4,4′-bipyridinium dichloride) is widely used as a redox cycler to stimulate superoxide production in organisms, cells and mitochondria. This superoxide production causes extensive mitochondrial oxidative damage, however there is considerable uncertainty over the mitochondrial sites of paraquat reduction and superoxide formation. Here we show that in yeast and mammalian mitochondria, superoxide production by paraquat occurs in the mitochondrial matrix, as inferred from manganese superoxide dismutase-sensitive mitochondrial DNA damage, as well as from superoxide assays in isolated mitochondria, which were unaffected by exogenous superoxide dismutase. This paraquat-induced superoxide production in the mitochondrial matrix required a membrane potential which was essential for paraquat uptake into mitochondria. This uptake was of the paraquat dication, not the radical monocation, and was carrier-mediated. Experiments with disrupted mitochondria showed that once in the matrix paraquat was principally reduced by complex I (mammals) or by NADPH dehydrogenases (yeast) to form the paraquat radical cation which then reacted with oxygen to form superoxide. Together this membrane potentialdependent uptake across the mitochondrial inner membrane and the subsequent rapid reduction to the paraquat radical cation explain the toxicity of paraquat to mitochondria.
Paraquat (1,1′-dimethyl-4,4′-bipyridinium dichloride; PQ) is used to increase superoxide (O 2 •-) flux when investigating oxidative stress (reviewed in 1,2). The paraquat dication (PQ   2+   ) accepts an electron from a reductant to form the paraquat monocation radical (PQ (Fig. 1A ). This redox cycling is a proximal cause of PQ toxicity, as indicated by the protection against PQ by superoxide dismutase (SOD) overexpression or administration of SOD mimetics (4) (5) (6) (7) (8) , and by the PQ hypersensitivity caused by SOD deficiency (9) (10) (11) .
PQ has been used to generate O 2 •-in systems ranging from isolated mitochondria (12) (13) (14) (15) and cultured mammalian cells (4, 14, 16, 17) , to whole organisms including Saccharomyces cerevisiae (18) (19) (20) (21) , Caenorhabditis elegans (22, 23) , Drosophila melanogaster (9, (24) (25) (26) and rodents (6, 11, 27) . In many of these studies, PQ increases mitochondrial oxidative damage; for example, mitochondrial expression of human peroxiredoxin 5 protects yeast more effectively against PQ toxicity than expression in the cytosol (19) ; flies overexpressing catalase in mitochondria are resistant to PQ, whereas enhancement of cytosolic catalase was not protective (24) ; RNAisilencing of MnSOD (the isoform of superoxide dismutase located in the mitochondrial matrix) in flies causes hypersensitivity to PQ (9) ; mice heterozygous for MnSOD show greater sensitivity to PQ than wild-type (11) ; and mitochondrial swelling is one of the earliest ultrastructural changes upon PQ exposure in vivo (28, 29) . Therefore the interaction of PQ with mitochondria is an important component of its toxicity, and PQ is used in experimental models of Parkinson disease to generate mitochondrial oxidative damage (30) . Consequently, there is considerable interest in identifying the sites of PQ 2+ reduction associated with mitochondria and in determining whether O 2 •-production by PQ occurs within mitochondria, or if it takes place outside and then passes into the matrix. The very negative reduction potential of PQ (PQ 2+ /PQ •+ , E 0 = -446 mV) (1) severely restricts its pool of possible intracellular reductants. However, there are a number of proposed sites for PQ 2+ reduction both inside and outside mitochondria including NAD(P)Hdependent flavoenzymes, such as microsomal NADPH-cytochrome P450 reductase (31, 32) , NADH-cytochrome b 5 oxidoreductase and NADH-coenzyme Q oxidoreductase of the mitochondrial outer membrane (28, 33) , and complex I of the mitochondrial inner membrane (34) . Here we show that PQ 2+ is taken up across the mitochondrial inner membrane by a carriermediated and membrane potential (∆ψ m )-dependent process, and that once in the matrix PQ 2+ is reduced to PQ •+ by complex I in mammalian mitochondria and by NADPH dehydrogenases in yeast. The PQ
•+ then reacts with oxygen to form O 2
•-and cause mitochondrial oxidative stress.
EXPERIMENTAL PROCEDURES
Chemicals -Coelenterazine (CLZ; 2-(phydroxybenzyl)-6-(p-hydroxyphenyl)-8-benzylimidazo [ Yeast Strains and Growth -The Saccharomyces cerevisiae strains used were: wildtype EG103 (MATα his3 leu2 trp1 ura3) (18) and CEN.PK2-1C (MATα his3 leu2 trp1 ura3) (35) , and the MnSOD knock-out (∆sod2) EG110 (EG103, sod2∆::TRP1) (36) . The S. cerevisiae deletion library (Open Biosystems) was derived from the wild-type strain BY4741 (MATa his3 leu2 met15 ura3). Yeast were cultured in the following liquid media: lactate (2% (v/v) DL-lactic acid, 0.3% yeast extract, 0.05% glucose, 0.05% CaCl 2 ⋅2H 2 O, 0.05% NaCl, 0.06% MgCl 2 ⋅6H 2 O, 0.1% KP i , 0.1% NH 4 Cl (all w/v); pH 5.5 NaOH), YPD (1% (w/v) yeast extract, 2% (w/v) peptone, 2% (w/v) glucose) and YPG (1% (w/v) yeast extract, 2% (w/v) peptone, 3% (v/v) glycerol). For plates, liquid media were supplemented with 2% (w/v) agar. YPG+E plates contained 1 mg.mL -1 erythromycin. For growth assays, 10 mL yeast cultures at A 600 ~0.1 were treated with PQ (0.01-10 mM) and incubated at 30ºC with shaking at 250 rpm. A 600 was measured after 48 h and was expressed as a percentage of the appropriate control without PQ. To screen for PQ-resistant yeast mutants, YPG medium containing a concentration gradient of PQ was prepared in 10 cm square Petri dishes (Sarstedt). A slant of YPG + 1 mM PQ was first poured and once set was overlaid with standard YPG to form a flat surface. Yeast suspensions were then spotted (~30,000 cells) in rows along the PQ concentration gradient (0-1 mM), incubated for 1 week a 30ºC, and growth was compared against a wild-type control on each plate.
Mitochondrial Preparations -Yeast mitochondria were isolated from lactate-grown wild-type (strain EG103) and ∆sod2 cultures as described previously (37, 38) . The protein concentration was measured by the bicinchoninic acid method with BSA as a standard (39) . Aliquots of the mitochondrial preparation mixed with 10 mg.mL -1 fatty acid-free BSA were snap-frozen and stored at -80°C and before use were thawed rapidly (~30 s at 30ºC), pelleted by centrifugation (2 min at 16,000 x g), and washed once in mannitol buffer (0.6 M mannitol, 10 mM Tris maleate, 5 mM KP i , 0.5 mM EDTA; pH 6.8 KOH). These mitochondria can maintain a ∆ψ m indistinguishable from that of freshly isolated mitochondria (data not shown). Mitochondria from rat liver and rat heart were prepared fresh by homogenization and differential centrifugation (40) . The protein concentration was determined by the biuret method with BSA as a standard (41). Rat liver and heart mitochondrial incubations were performed in KCl buffer (120 mM KCl, 10 mM HEPES, 1 mM EGTA; pH 7.2 KOH). When required, mitochondria were disrupted with a sonicator (Misonix 3000, setting 3) for 3 x 5 s periods at 30 s intervals on ice. Bovine heart mitochondrial membranes were prepared by mechanical disruption of isolated bovine heart mitochondria (42), and were resuspended in KP i buffer (50 •-production was inferred from the rate of aconitase inactivation (15) . O 2
•-was also assayed by chemiluminescence of coelenterazine (CLZ) in a luminometer (Berthold AutoLumatPlus LB 953) over 5 min with cumulative readings for 5 s every 30 s (47, 48) and was expressed as relative light units (RLU).s -1 . Samples were incubated in a 1 mL volume at 30ºC with 2 µM CLZ. H 2 O 2 efflux from heart mitochondria was assayed using a fluorometer (Shimadzu RF-5301) by incubating heart mitochondria at 37ºC in a stirred 2.5 mL volume with 5 U.mL -1 horseradish peroxidase and 50 µM Amplex Red (15) Quantitative determinations were based on the height of the maximum peak (Fig. 7A ), which gave a linear standard curve in the range tested (0-250 µM; Fig. 7B ). The EPR signal of the SO 2
•-radical in the dithionite solution did not interfere with quantitation of the PQ
•+ radical (data not shown). PQ
•+ formation by hypoxic mitochondria was monitored by following an increase in A 603 over time with a spectrophotometer (DW-2000 SLM-Aminco), equipped with stirring and thermostatted at 30ºC. The suspension was rendered anaerobic by purging with argon and sealing the 3 mL quartz cuvette. Following a 5-10 min incubation, samples were subjected to absorbance readings (500-700 nm), firstly while still under anaerobic conditions and then following exposure to air. Difference spectra ± O 2 were then determined to diagnose PQ
•+ radical formation. Mitochondrial Uptake of PQ -Ionselective electrodes were constructed and used as described (53, 54) , except that the plasticizer dioctyl phthalate was replaced by 2-fluoro-2′-nitrodiphenyl ether (55) , which greatly improved membrane selectivity for PQ. Electrodes were characterized for either PQ or 1-methyl-4-phenylpyridinium (MPP + ) by filling and soaking overnight in a 10 mM aqueous solution. Incubations were performed in a stirred 3 mL chamber, thermostatted at 30ºC. The PQ-electrode response was linear with the log 10 
RESULTS AND DISCUSSION

PQ Increases Mitochondrial Matrix O 2
•-within Intact Yeast -Growth of wild-type yeast on the non-fermentable substrate glycerol was more PQ-sensitive than on the fermentable substrate glucose ( Fig. 2A) , indicating that PQ disrupted mitochondrial function. This disruption was due to O 2
•-within mitochondria, as growth of yeast lacking mitochondrial SOD (∆sod2) on the nonfermentable substrate lactate was far more PQsensitive than that of the wild-type strain (Fig. 2B ) (56). To see if PQ caused damage in the mitochondrial matrix, we studied its effect on the accumulation of specific point mutations in mitochondrial DNA (mtDNA) using the erythromycin resistance (Ery R ) assay (50, 57) , and found that PQ elevated mtDNA damage (Fig. 2C) . The damage to mtDNA was due to O 2
•-within the mitochondrial matrix, as PQ only increased the formation of petite colonies in the ∆sod2 yeast strain and not the wild type (Fig. 2D) •-production in isolated yeast mitochondria as measured by the O 2
•--specific chemiluminescence of the membranepermeant probe coelenterazine (CLZ). In the presence of the respiratory substrate ethanol, PQ caused a dramatic dose-dependent increase in O 2
•-production by ∆sod2 mitochondria, but not wildtype mitochondria (Fig. 3A) . Surprisingly, this O 2
•-production was completely blocked by abolishing the mitochondrial membrane potential (∆ψ m ) with the uncoupler carbonyl cyanide p-trifluoromethoxyphenylhydrazone (FCCP) (Fig. 3A) . Addition of exogenous SOD did not affect PQinduced O 2
•-production ( Fig. 3B) , consistent with PQ generating O 2
•-inside the mitochondrial matrix.
The CLZ assay did not detect matrix O 2
•-production in wild-type yeast mitochondria (Fig. 3A) •-outside the mitochondrial matrix. Aconitase inactivation also showed a dosedependent increase in O 2
•-production with PQ within isolated yeast mitochondria that required a respiratory substrate, was blocked by FCCP ( Fig. 3C) and was unaffected by exogenous SOD (Fig. 3D) .
A similar pattern of O 2 •-production was obtained by both the CLZ and the aconitase assays when glycerol-3-phosphate (5 mM) was used as a respiratory substrate (data not shown). Together these data indicate that PQ produces O 2
•-inside the mitochondrial matrix in isolated yeast mitochondria in the presence of a respiratory substrate and a ∆ψ m . The requirement for a ∆ψ m could be to enhance the uptake of PQ into the mitochondrial matrix and/or to assist in its reduction by the respiratory chain.
PQ Increases O 2 •-
Production by Mammalian Mitochondria -To see if the interaction of PQ with mammalian and yeast mitochondria was similar, we next investigated its effects on O 2
•-production within isolated rat heart mitochondria. As with yeast mitochondria, there was a dose-dependent inactivation of aconitase by PQ that required a respiratory substrate, was blocked by FCCP (Fig. 3E) , and was unaffected by exogenous SOD (Fig. 3F ). Thus PQ-induced O 2
•-production by mammalian mitochondria is similar to that of yeast mitochondria. Interestingly, the rate of PQ-induced aconitase inactivation was greater for heart mitochondria respiring on succinate than on the complex I-linked substrates glutamate/malate, and the complex I inhibitor rotenone prevented O 2
•-formation by PQ in the presence of succinate (Fig. 3E) .
To investigate the intriguing substrateand ∆ψ m -dependence of PQ-induced O 2
•-production in real time, we measured H 2 O 2 efflux, derived from matrix O 2
•-, in heart mitochondria (61). In the absence of PQ, energizing heart mitochondria with glutamate/malate resulted in negligible H 2 O 2 efflux (Fig. 4A ) that increased substantially when succinate was the substrate (Fig. 4B ). This increase with succinate was due to the high ∆ψ m and fully reduced coenzyme Q pool driving reverse electron transport through complex I that led to O 2
•-production (61). O 2 •-production from succinate was blocked by abolishing the ∆ψ m with FCCP ( Fig. 4B) , with the complex III inhibitor stigmatellin (data not shown), or by inhibiting electron entry from the coenzyme Q pool into complex I with rotenone ( Fig. 4D) .
Addition of PQ to mitochondria respiring on glutamate/malate increased H 2 O 2 efflux (Fig.  4C ) and this was decreased by abolishing the ∆ψ m with rotenone ( Fig. 4C ) or stigmatellin (data not shown), however these inhibitors were only effective when present from the beginning of the incubation; when they were added after H 2 O 2 production was well established they increased H 2 O 2 efflux ( Fig. 4C and data not shown). In contrast, FCCP blocked the PQ-induced H 2 O 2 efflux when added early or late in the incubation (Fig. 4A) . This difference may occur because both rotenone and stigmatellin are respiratory inhibitors that cause a build-up of electrons within complex I, as well as abolishing the ∆ψ m . In contrast, the uncoupler FCCP abolishes the ∆ψ m while oxidizing complex I. These findings are consistent with the uptake of PQ into mitochondria requiring a ∆ψ m and the PQ in the matrix then interacting with a reduced complex I to generate O 2
•-. Addition of PQ to mitochondria respiring on succinate led to a greater efflux of H 2 O 2 than when glutamate/malate was used as a respiratory substrate (Fig. 4E) , consistent with the aconitase inactivation data (Fig. 3E ). This H 2 O 2 efflux caused by PQ in the presence of succinate was inhibited by FCCP ( Fig. 4B) , rotenone ( Fig. 4D ) and stigmatellin (data not shown). However, in contrast to when glutamate/malate was the respiratory substrate, these compounds were equally effective at preventing H 2 O 2 efflux when added at the beginning or in the middle of the incubation (Figs. 4B & 4D, and data not shown). Stigmatellin and FCCP abolish the ∆ψ m and would thus prevent any putative ∆ψ m -dependent PQ uptake as well as reverse electron transport through complex I. However, rotenone would not abolish the ∆ψ m and in these experiments would only prevent the movement of electrons into complex I driven by reverse electron transport. This shows that complexes II and III are not involved in the production of O 2
•-by PQ. These findings indicate that in mammalian mitochondria respiring on succinate, O 2
•-production by PQ occurs at complex I and requires a ∆ψ m both to cause the accumulation of PQ into mitochondria and to drive electrons from the coenzyme Q pool into complex I by reverse electron transport. Thus the main site of PQ reduction in mammalian mitochondria is likely to be on complex I.
Sites of O 2 •-Production by PQ within Mitochondria -To further investigate the sites of PQ
•+ generation in mammalian mitochondria and to determine whether a ∆ψ m was essential for this, we measured O 2
•-production by bovine heart mitochondrial membranes using the CLZ chemiluminescence assay. In this system, the respiratory complexes are exposed to PQ without requiring uptake into the mitochondrial matrix and reverse electron transport into complex I is not possible.
PQ did not enhance O 2 •-production by bovine heart mitochondrial membranes respiring on succinate (Fig. 5A) •-production from PQ via complex I through ∆ψ m -dependent reverse electron transport (61) .
Incubation of bovine heart mitochondrial membranes with NADH led to a dramatic PQ dose-dependent stimulation of O 2
•-production (Fig. 5B) . In this situation rotenone stimulated O 2
•-production by increasing the reduction state of complex I, consistent with the H 2 O 2 assay results obtained for intact heart mitochondria (Fig. 4C) . The flavoprotein inhibitor diphenyleneiodonium (DPI) prevented the PQ-induced O 2
•-production (Fig. 5B) . Furthermore NADPH resulted in negligible O 2
•-production compared to that by NADH (Fig. 5B) . These data indicate that complex I can reduce PQ 2+ to PQ •+ thereby producing O 2
•-, and are consistent with an earlier report with isolated complex I (34).
We cannot entirely eliminate the possibility that there are other sites of PQ 2+ reduction in mammalian mitochondria. However, the data in Fig. 4D show that rotenone almost completely abolished H 2 O 2 efflux for mitochondria respiring on succinate in the presence of PQ. Under these conditions the mitochondrial NADH and NADPH pools are reduced, the ∆ψ m is high and only access to complex I is prevented. Furthermore, when sonicated heart mitochondria were incubated with NADPH there was negligible O 2
•-production compared to the rotenone-sensitive O 2
•-production in the presence of NADH (Fig. 5C ). These data are consistent with complex I being the major site of PQ 2+ reduction within mammalian mitochondria.
We next investigated the potential sites of PQ-induced O 2
•-production within yeast mitochondria, which do not contain complex I. For this ∆sod2 yeast mitochondria were broken by sonication and then incubated with the electron donors NADH, NADPH, succinate or glycerol-3-phosphate along with PQ, and O 2
•-production was measured (Fig. 5D and data not shown) . This indicated that the main substrate for PQ 2+ reduction was NADPH and that NADH had a negligible role. This O 2
•-production was completely abolished by the flavin inhibitor DPI indicating that reduction occurred through a flavin-containing NADPH dehydrogenase (Fig. 5D) .
Therefore within mitochondria, PQ in the presence of NAD(P)H will lead to the formation of O 2
•-and the main sites for this are complex I in mammalian mitochondria and intramitochondrial NADPH dehydrogenases in yeast mitochondria. There is no requirement for a ∆ψ m to reduce PQ 2+ to PQ
•+ once the PQ is within mitochondria and when NADH is used as the substrate; however, for mammalian mitochondria respiring on succinate, PQ reduction requires a ∆ψ m to drive electrons from the coenzyme Q pool into complex I.
Investigating the ∆ψ m -dependence of PQ
2+
Uptake by Mitochondria -The above findings indicate that PQ 2+ in the mitochondrial matrix can increase matrix O 2
•-production in the absence of a ∆ψ m . This suggests that the ∆ψ m -dependence of PQ-induced O 2
•-production occurs because the ∆ψ m drives PQ uptake into the matrix. Many lipophilic cations and dications are taken up electrophoretically into mitochondria by direct passage through the phospholipid bilayer driven by the ∆ψ m in response to the Nernst equation (44,62). Significantly, the structurally similar compound 1-methyl-4-phenylpyridinium (MPP + ; Fig. 1B ) is accumulated by mitochondria in a ∆ψ m -dependent manner by direct passage through the inner membrane (54) . We confirmed the ∆ψ mdependent uptake of MPP + into energized yeast mitochondria using a MPP + -selective electrode and showed that this uptake could be further stimulated by the lipophilic anion tetraphenylborate (TPB -; Fig. 6A ), which facilitates the direct passage of lipophilic cations across the membrane (63) . However similar experiments using a PQ-selective electrode showed no measurable PQ uptake into energized yeast mitochondria (Fig. 6B) (64) . However while the PQ-selective electrode eliminates the possibility of bulk movement of PQ 2+ across the membrane, it will only detect large-scale redistributions. To see if there was a low capacity uptake system that led to ∆ψ mdependent uptake of PQ 2+ into mitochondria, we utilized more sensitive detection methods based on either EPR (Figs. 7A & 7B ) or radiolabeled PQ and were able to show time-dependent uptake of PQ into yeast mitochondria (Fig. 7C ). This uptake was ∆ψ m -sensitive as the presence of the uncoupler FCCP or the complex III inhibitor myxothiazol at the start of the incubation completely prevented PQ uptake (Fig. 7D) . Furthermore the K + /H + antiporter nigericin (1 µM), which increases ∆ψ m by converting the mitochondrial pH gradient into a ∆ψ m , stimulated PQ uptake (data not shown). Addition of FCCP at the end of the incubation did not lead to immediate reversal of the accumulation (Fig. 7D) , unlike the situation with MPP + (Fig. 6A) . PQ uptake into yeast mitochondria was also driven by the respiratory substrates succinate and glycerol-3-phosphate (data not shown). Qualitatively similar data were obtained for mammalian mitochondria, which also showed ∆ψ m -dependent uptake of PQ that was prevented, but not reversed by uncoupling (Fig. 7E) .
When the initial rate of uptake of PQ ] (1.25-20 mM) an apparent saturation was found with half maximal uptake at about 3.5 mM (Fig. 7F ). While these data are consistent with a saturable, low affinity, low capacity mediated uptake system, a definitive interpretation of these kinetic data is not possible. This is because incubating mitochondria with increasing PQ 2+ concentrations from above ~1 mM for yeast mitochondria gradually lowers the ∆ψ m (data not shown). Consequently the decrease in uptake with increasing [PQ 2+ ] may be due to a combination of saturation and of the progressive decrease in ∆ψ m as the PQ 2+ concentration increases. This interpretation is supported by the lack of fit of these data to any of the standard transformations of Michaelis-Menten kinetics.
Nature of the Mitochondrial PQ Uptake System -The data in Fig. 7 are consistent with, but not proof of, carrier-mediated uptake of PQ into mitochondria. Carrier-mediated PQ transport has been reported in lung alveolar epithelial cells by the polyamine transport system, which is inhibited by putrescine (65), and across the blood-brain barrier via the neutral amino acid transporter, which is inhibited by L-valine (66) . To explore whether PQ uptake into mitochondria occurs through a carrier in the mitochondrial inner membrane we focussed on yeast as the activity was greater, deletion libraries were available and many mitochondrial carriers are similar in yeast and mammals.
If uptake is carrier-mediated then structurally similar compounds such as MPP + , diquat and putrescine (Fig. 1B) (Fig. 8A) . Neither vanadate (an inhibitor of ABC transporters) or oligomycin (an inhibitor of ATP synthase) affected PQ uptake into mitochondria (Fig. 8B) , suggesting that uptake does not depend on intramitochondrial ATP. The thiol alkylating agent N-ethyl maleimide (NEM) inhibits many mitochondrial transporters (e.g. 67) and it had a considerably greater effect on PQ uptake than it did on ∆ψ m (Fig. 8C) .
These data are consistent with a mitochondrial transporter mediating ∆ψ m -dependent, but ATP-independent, uptake of PQ into mitochondria. Possible candidates are the mitochondrial carrier family which has 35 members in yeast mitochondria (68, 69) . We hypothesized that yeast lacking the putative mitochondrial PQ carrier would show resistance to PQ on non-fermentable medium. We screened the growth on fermentable medium supplemented with PQ of 29 yeast strains in which the genes for proven or putative mitochondrial carriers had been deleted. The 0-1 mM PQ gradient in the plates showed the PQ sensitivity of the wild-type strain and detected a number of strains such as ∆ctp1 that were clearly resistant to PQ (Fig. 8D) . Of the 29 deletion strains tested, 8 were resistant to PQ, however PQ uptake by mitochondria isolated from these strains was indistinguishable from wild-type (Table 1) . Thus deletion of these carriers protects against mitochondrial damage by PQ through other mechanisms. For example, deletion of the citrate transporter Ctp1p may protect by increasing the matrix citrate concentration thereby preventing O 2
•-damage to the sensitive iron-sulfur center in the active site of aconitase. Therefore it is not possible to use a simple PQ screen alone to identify the putative PQ uptake system, making its identification significantly more difficult. Furthermore, as the apparent affinity of PQ for its putative carrier was around 3 mM, while the affinities of substrates for other carriers are often in the 10-100 µM range (70), it is likely that PQ is a poor substrate for its carrier or carriers, making it more challenging to identify. Even though the putative PQ carrier(s) remain to be identified, the data in Figs. 3 radical is only stable in the absence of O 2 and has a distinctive visible absorption spectrum (Fig. 9A) . When yeast mitochondria were incubated anaerobically with NADPH there was some formation of PQ •+ as indicated by the increase in absorption at 603 nm (Fig. 9B, inset right) and by the difference spectrum in the presence and absence of O 2 (Fig. 9B) . However, there was no PQ 2+ reduction by ethanol, NADH (Fig. 9B) , or NADP (data not shown). In rat heart mitochondria there was some formation of PQ
•+ in the presence of NADH, but not by succinate or NADPH (Fig. 9C) . Therefore under conditions where there was extensive O 2
•-production within mitochondria (Figs. 3 & 4 •-production within mitochondria by enhancing the net uptake of PQ into mitochondria. The PQ 2+ dication is not taken up into energized mitochondria directly through the mitochondrial inner membrane because its double charge greatly increases its activation energy for movement through the hydrophobic core of the membrane (44,64). However the Born energy component of this activation energy is proportional to the square of its charge and for the PQ •+ radical cation will be 4-fold lower than the PQ 2+ dication. The structure and charge of the PQ •+ monocation is very similar to the MPP + monocation (Fig. 1B) , which is taken up directly through the membrane (54 and Fig. 6A (Fig. 9B) . Under these conditions, no increase in net PQ uptake was observed (data not shown), even when PQ
•+ was generated in the vicinity of mitochondria. To summarize, the increase in mitochondrial O 2
•-caused by PQ is predominantly due to O 2
•-generated within mitochondria.
Conclusions -Here we have demonstrated how PQ can act to increase intramitochondrial O 2
•-production (Fig. 10) . The major mode of O 2
•-production requires the ∆ψ m -dependent uptake of the PQ 2+ dication by energized mitochondria. This uptake does not seem to involve movement of the dication through the phospholipid bilayer, but instead is carrier-mediated by a putative PQ carrier protein or proteins, which require a ∆ψ m to drive PQ accumulation into the mitochondria. Once within mitochondria, the PQ is largely retained, even after the ∆ψ m has been abolished. This ∆ψ mdependence of PQ uptake into mitochondria may help explain findings in the literature that flies with targeted expression of human uncoupling protein 2 in the mitochondria of neurons show increased resistance to PQ (25) and that treatment of yeast cultures with the complex III inhibitor antimycin A causes PQ resistance (72) , presumably because the inhibition of ∆ψ m prevents mitochondrial uptake.
The PQ within mitochondria then goes on to produce O 2 •-production does not occur in mitochondrial membranes respiring on succinate, requires a ∆ψ m even after significant amounts of PQ have been accumulated by mitochondria and is inhibited by rotenone. Therefore this PQ 2+ reduction is due to the action of complex I.
The requirement for a ∆ψ m and blocking by rotenone is similar to the production of O 2
•-from complex I by reverse electron transport and suggests that under conditions of a reduced coenzyme Q pool and a high ∆ψ m , electrons are forced into complex I where reduction of PQ 2+ takes place. Whether this is the same site as that of O 2
•-production by complex I during reverse electron transport or if this site is the same for PQ 2+ reduction during NADH oxidation is currently unclear, but investigation of this point may help shed light on the mechanisms of O 2
•-production by complex I. That complex I is the major site of O 2
•-production within mitochondria exposed to PQ, and that complex I damage is a major factor in idiopathic Parkinson disease, strongly supports PQ toxicity as a useful model for Parkinson disease (73) .
While this manuscript was in preparation another investigation of the interaction of PQ with mammalian mitochondria was published by Castello et al. (74) . That paper also reported that mitochondria are a major site of ∆ψ m -dependent reactive oxygen species formation by PQ. However, their suggestion that complex III in the respiratory chain is the major site of PQ reduction contrasts with our findings that complex I is the only significant site of PQ reduction within mammalian mitochondria. Furthermore, as the reduction potential for PQ 2+ /PQ
•+ (-446 mV) is far lower than the potentials spanned by complex III (~0 mV to +250 mV) and the lowest E m'7 for a Q cycle intermediate (the ubiquinolate radical anion/ubiquinone couple) is only -160 mV (75) , complex III is unlikely to reduce PQ. Another difference between Castello et al. and our findings is their report that succinate and PQ addition to isolated mitochondria leads to H 2 O 2 production which is only partly inhibited by rotenone (74), whereas we find complete inhibition. It may be that brain mitochondrial preparations contain endogenous, NADH-linked substrates that increase rotenone-sensitive PQ reduction. The other difference is that we show uptake of PQ into mitochondria, which is ∆ψ m -dependent in both yeast and mammalian mitochondria, while Castello et al. report that PQ uptake by mitochondria is not dependent on ∆ψ m . These differences may arise from the greater sensitivity of the two methods we employed, namely the uptake of radiolabelled compound and analysis of uptake by EPR, compared to the HPLC determination used by Castello et al. (74) .
In conclusion, we have shown that PQ causes mitochondrial oxidative damage in mammalian systems following its ∆ψ m -dependent accumulation into the mitochondrial matrix. Within the matrix, PQ 2+ is reduced by complex I either via electrons from NADH-linked substrates or from the coenzyme Q pool driven into complex I by reverse electron transport. The PQ
•+ radical thus formed rapidly reacts with O 2 to give O 2
•-, and due to its short half-life, PQ
•+ will preferentially generate O 2
•-close to complex I. Thus within mammalian systems mitochondria are a major site of O 2
•-formation and complex I is likely to be both a site and target for damage of this O 2
•-production. Effect of MnSOD deletion and PQ exposure on petite formation. Wild-type (EG103) and ∆sod2 yeast were cultured in YPD medium ± PQ (100 µM). Petite mutants were identified by the tetrazolium overlay technique. Data are the means ± SD of three independent experiments. Statistical significance was calculated with a Student's two-tailed t-test. n/s (not significant), P > 0.05; *, P < 0.05; **, P < 0.01. •-production as determined by the CLZ chemiluminescence assay is insensitive to exogenous SOD. Experiments were performed as for A in ∆sod2 mitochondria with PQ (10 mM) and SOD (100 U.mL -1 ) as indicated. Data are the means ± SD of four determinations. C. As for A, except that O 2
•-production was determined by the aconitase inactivation assay in wild-type mitochondria (0.3 mg protein.mL -1 ). Data are the means ± SD of four determinations. D. PQ-induced mitochondrial O 2
•-production, as inferred from aconitase inactivation, is insensitive to exogenous SOD. Experiments were performed as for C with PQ (10 mM) and SOD (50 U.mL -1 ) as indicated. Data are the means ± range of two determinations. E. O 2
•-production in rat heart mitochondria was determined by the aconitase inactivation assay. Heart mitochondria (2 mg protein.mL -1 ) were incubated for 10 min at 37ºC in KCl buffer supplemented with 0.1% (w/v) BSA. Substrate (5 mM glutamate/malate, or 5 mM succinate ± 4 µg.mL -1 rotenone), uncoupler (1 µM FCCP) and PQ (0.1 or 1 mM) were present as indicated. Data are the means ± SD of three determinations. F. PQ-induced O 2
•-production in rat heart mitochondria, as determined by the aconitase inactivation assay, is insensitive to exogenous SOD. As for E, except that the incubations were supplemented with SOD (50 U.mL -1 ) where indicated. Data are the means ± SD of three-four determinations. -1 ). E. Rates of H 2 O 2 efflux from rat heart mitochondria, determined from the above traces. Data are the means ± SD of three-four determinations. As for A, except that a PQselective electrode was calibrated with three successive additions of 10 µM PQ 2+ (arrowheads). The presence of TPB -had no effect (data not shown). Table 1 . were incubated anaerobically (argon-purged) for 10 min at 30ºC in the presence of 1 mM PQ ± ethanol (5 mM), NADH (1 mM) or NADPH (1 mM). Samples were then subjected to absorbance readings (500-700 nm), firstly while still under anaerobic conditions and then following exposure to air, and the difference spectra ± O 2 were determined. The inset shows a typical set of original raw data for the incubation with NADPH. C. PQ
•+ radical formation by anaerobic mammalian mitochondria. Rat heart mitochondria (1 mg protein.mL -1 ) were incubated anaerobically in KCl buffer + 0.01% BSA for 5 min at 37ºC in the presence of 1 mM PQ ± NADH (1 mM), NADPH (1 mM) or succinate (5 mM). Difference spectra ± O 2 to diagnose PQ
•+ radical formation were performed as described for B. •+ can be generated at complex I by reverse electron transport whereby electrons from the CoQ pool (e.g. from the substrate succinate) are driven into complex I by the ∆ψ m . By analogy with the structurally similar MPP + , PQ •+ generated outside mitochondria may be taken up into the matrix by direct passage across the membrane. However the short lifetime of PQ
•+ at physiological [O 2 ] probably limits the contribution of this process to PQ 2+ uptake into mitochondria. Table 1 . Summary of the screen for PQ resistance in mutants from the yeast deletion library. Experiments were performed as described in the methods section. A typical plate is shown in Fig. 8D . For each mutant, the deleted gene (a), corresponding ORF (b), and a description of the carrier/transporter function/substrate (c) are listed. This information was compiled from the Saccharomyces Genome Database (www.yeastgenome.org) and a review (68) . Candidates have been grouped as belonging to the mitochondrial carrier family, and other transporters (mainly ABC transporters). To assess PQ resistance, growth of mutant strains was compared against the isogenic wild-type control on each plate (d). -, more sensitive to PQ than wild-type; = same as wild-type; +/++/+++, more resistant to PQ than wild-type (low/medium/high). Note that it was not possible to screen all mitochondrial carriers and transporters, because some deletion strains are lethal and others are non-viable on non-fermentable media. Mitochondria were isolated from selected strains, and PQ uptake ± FCCP was tested by the EPR technique. In all cases, mitochondria isolated from carrier mutants showed ∆ψ m -dependent uptake of PQ which was indistinguishable from that of wild-type mitochondria. n.d., not determined. Figure 10 
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